Drug news
Ferring licenses elobixibat from Albireo for Chronic Constipation and IBS.
Ferring has licensed from Albireo the world rights to elobixibat, excluding those territories held by Ajimoto. Elobixibat is a first-in-class investigational drug in development for Chronic Constipation and Irritable Bowel Syndrome with Constipation.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.